Study of Setmelanotide Effects on QTc (Corrected QT) Interval in Healthy Subjects
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This is a double-blind, randomized, placebo- and positive-controlled, parallel group, 3-arm
study to assess the potential for therapeutic and supratherapeutic concentrations of
setmelanotide to affect the QTcF interval compared with placebo.